Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026)
Fortrea Holdings (FTRE) posted Total Liabilities of $2.2 billion for Q1 2026, little changed on a QoQ basis from $2.2 billion in Q4 2025, and down 4.63% year-over-year from $2.3 billion in Q1 2025.
Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026) Analysis & Trends
Fortrea Holdings' Total Liabilities history runs 5 years deep, the most recent figure standing at $2.2 billion for Q1 2026.
- Quarterly Total Liabilities fell 4.63% year-over-year to $2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (down 4.63% YoY) and the FY2025 annual result came in at $2.2 billion, down 2.91% from the prior year.
- Total Liabilities was $2.2 billion for Q1 2026 at Fortrea Holdings, roughly flat from $2.2 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $2.6 billion in Q1 2024 and bottomed at $945.3 million in Q4 2022.
- A 5-year average of $2.2 billion and a median of $2.2 billion in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities surged 177.0% — and 2024, when it dropped 19.22%.
- Fortrea Holdings' Total Liabilities stood at $945.3 million in 2022, then soared by 177.0% to $2.6 billion in 2023, then decreased by 15.34% to $2.2 billion in 2024, then decreased by 2.91% to $2.2 billion in 2025, then grew by 0.25% to $2.2 billion in 2026.
- Business Quant data shows FTRE's Total Liabilities at $2.2 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 2.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Bn |
| Dec 31, 2025 | 2.15 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | 2.25 Bn |
| Mar 31, 2025 | 2.26 Bn |
| Dec 31, 2024 | 2.22 Bn |
| Sep 30, 2024 | 2.15 Bn |
| Jun 30, 2024 | 2.10 Bn |
| Mar 31, 2024 | 2.65 Bn |
| Dec 31, 2023 | 2.62 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Dec 31, 2022 | 945.30 Mn |